NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Stockholders of record on Friday, January 25th will be given a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 annualized dividend and a dividend yield of 3.21%. The ex-dividend date is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its earnings results on Wednesday, February, 20th. The pharmacy operator reported $2.14 earnings per share for the quarter, beating the Zacks' consensus estimate of $2.07 by $0.07. The pharmacy operator earned $54.42 billion during the quarter, compared to analyst estimates of $53.78 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The business's quarterly revenue was up 12.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.92 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided EPS guidance of $6.68-6.88 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.34. CVS Health also updated its FY 2019 guidance to $6.68-6.88 EPS.

17 brokers have issued 1 year target prices for CVS Health's stock. Their forecasts range from $68.00 to $100.00. On average, they expect CVS Health's share price to reach $87.25 in the next year. This suggests a possible upside of 39.9% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media headlines about CVS stock have trended somewhat positive this week, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CVS Health earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave news articles about the pharmacy operator a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future.

CVS Health saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 14,420,741 shares, an increase of 35.1% from the January 15th total of 10,671,652 shares. Based on an average daily volume of 9,924,659 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.1% of the shares of the company are sold short. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), HS SPINCO INC/SH (CVET), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Bank of America (BAC), Johnson & Johnson (JNJ), General Electric (GE), Cisco Systems (CSCO), Alibaba Group (BABA), Intel (INTC), Starbucks (SBUX) and NVIDIA (NVDA).

CVS Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.12%), Oregon Public Employees Retirement Fund (2.46%), Barrow Hanley Mewhinney & Strauss LLC (1.88%), Northern Trust Corp (1.76%), Geode Capital Management LLC (1.62%) and Bank of New York Mellon Corp (1.43%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp, Dimensional Fund Advisors LP, Diamond Hill Capital Management Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $62.35.

CVS Health has a market capitalization of $63.52 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]